Literature DB >> 1138741

The effects of magnesium deficiency of ketamine sleeping times in the rat.

B G Douglas, R Dagirmanjian.   

Abstract

Young growing rats were maintained on a magnesium deficient diet, and injected with ketamine after 7, 11, 14, and 18 days on the diet. A comparison of the sleeping times, as measured by the loss of the righting reflex after injections of three doses of ketamine, was made with rats similarly maintained on a control diet. Tolerance with successive injections to ketamine, indicated by a decrease in sleeping time, was noted only among the control rats. After 14 and 18 days on the diet, the magnesium deficient rats showed no tolerance to the earlier injections, but their sleeping times were longer than their control counterparts. In rats injected for the first time on day 14 of the diet, the magnesium deficient rats showed significantly longer sleeping times than the control rats; this suggests that the difference in sleeping times between groups is not entirely dependent upon the development of tolerance to the drug seen in the control rats. In addition, a sex difference was noted, with female rats sleeping longer with ketamine than male rats.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1138741     DOI: 10.1093/bja/47.3.336

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  8 in total

1.  Effects of repeated doses of ketamine on sleeping times in rats [proceedings].

Authors:  A Livingston; A E Waterman
Journal:  Br J Pharmacol       Date:  1976-07       Impact factor: 8.739

2.  The anxiolytic effect of salicylic acid is mediated via the GABAergic system in the fear potentiated plus maze behavior in rats.

Authors:  Sahel Motaghi; Hadi Moghaddam Dizaj Herik; Gholamreza Sepehri; Mehdi Abbasnejad; Saeed Esmaeli-Mahani
Journal:  Mol Biol Rep       Date:  2021-11-19       Impact factor: 2.316

3.  The development of tolerance to ketamine in rats and the significance of hepatic metabolism.

Authors:  A Livingston; A E Waterman
Journal:  Br J Pharmacol       Date:  1978-09       Impact factor: 8.739

4.  On the interaction of drugs with the cholinergic nervous system. I. Tolerance to phencyclidine derivatives in mice: pharmacological characterization.

Authors:  I Pinchasi; S Maayani; M Sokolovsky
Journal:  Psychopharmacology (Berl)       Date:  1978-01-31       Impact factor: 4.530

5.  Alteration of plasma ketamine levels in mice by probenecid.

Authors:  J N Davisson
Journal:  Experientia       Date:  1979-08-15

6.  Sex- and dose-dependent abuse liability of repeated subanesthetic ketamine in rats.

Authors:  Kristin J Schoepfer; Caroline E Strong; Samantha K Saland; Katherine N Wright; Mohamed Kabbaj
Journal:  Physiol Behav       Date:  2017-10-18

7.  A pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder.

Authors:  M S Milak; C J Proper; S T Mulhern; A L Parter; L S Kegeles; R T Ogden; X Mao; C I Rodriguez; M A Oquendo; R F Suckow; T B Cooper; J G Keilp; D C Shungu; J J Mann
Journal:  Mol Psychiatry       Date:  2015-08-18       Impact factor: 15.992

8.  Assessment of Relationship of Ketamine Dose With Magnetic Resonance Spectroscopy of Glx and GABA Responses in Adults With Major Depression: A Randomized Clinical Trial.

Authors:  Matthew S Milak; Rain Rashid; Zhengchao Dong; Lawrence S Kegeles; Michael F Grunebaum; R Todd Ogden; Xuejing Lin; Stephanie T Mulhern; Raymond F Suckow; Thomas B Cooper; John G Keilp; Xiangling Mao; Dikoma C Shungu; J John Mann
Journal:  JAMA Netw Open       Date:  2020-08-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.